Microbial biotransformation of furosemide for environmental risk assessment: identification of metabolites and toxicological evaluation

Microbial degradation of fluorinated drugs: biochemical pathways, impacts on the environment and potential applications

(2016) Cormac D. Murphy   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Quinoline biodegradation by filamentous fungus Cunninghamella elegans and adaptive modifications of the fungal membrane composition

(2016) Aleksandra Felczak et al.   ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH

Seasonal occurrence, removal, mass loading and environmental risk assessment of 55 pharmaceuticals and personal care products in a municipal wastewater treatment plant in Central Greece

(2016) Myrsini Papageorgiou et al.   SCIENCE OF THE TOTAL ENVIRONMENT

Biotransformations of organic compounds mediated by cultures of Aspergillus niger

(2015) Igor A. Parshikov et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Electro-Oxidation of the Pharmaceutical Furosemide: Kinetics, Mechanism, and By-Products

(2015) Hugo Olvera-Vargas et al.   CLEAN-Soil Air Water

An overview on the advanced oxidation processes applied for the treatment of water pollutants defined in the recently launched Directive 2013/39/EU

(2015) Ana R. Ribeiro et al.   ENVIRONMENT INTERNATIONAL

Pharmaceuticals and iodinated contrast media in a hospital wastewater: A case study to analyse their presence and characterise their environmental risk and hazard

(2015) A. Mendoza et al.   ENVIRONMENTAL RESEARCH

Improving Environmental Risk Assessment of Human Pharmaceuticals

(2015) Marlene Ågerstrand et al.   ENVIRONMENTAL SCIENCE & TECHNOLOGY

Pharmaceuticals in the environment: Biodegradation and effects on natural microbial communities. A review

(2015) Anna Barra Caracciolo et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Characterization of Pharmaceuticals and Personal Care products in hospital effluent and waste water influent/effluent by direct-injection LC-MS-MS

(2015) Tiago S. Oliveira et al.   SCIENCE OF THE TOTAL ENVIRONMENT

Occurrence of pharmaceuticals in a water supply system and related human health risk assessment

(2015) Vanessa de Jesus Gaffney et al.   WATER RESEARCH

Elucidation of transformation pathway of ketoprofen, ibuprofen, and furosemide in surface water and their occurrence in the aqueous environment using UHPLC-QTOF-MS

(2014) A. Jakimska et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Anticipating the fate and impact of organic environmental contaminants: A new approach applied to the pharmaceutical furosemide

(2014) Céline Laurencé et al.   CHEMOSPHERE

Pharmaceuticals in hospital wastewater: Their ecotoxicity and contribution to the environmental hazard of the effluent

(2014) Orias Frédéric et al.   CHEMOSPHERE

Pharmaceuticals in the environment: scientific evidence of risks and its regulation

(2014) A. Kuster et al.   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

An uncertainty and sensitivity analysis applied to the prioritisation of pharmaceuticals as surface water contaminants from wastewater treatment plant direct emissions

(2014) Sérgio Alberto Morais et al.   SCIENCE OF THE TOTAL ENVIRONMENT

A framework for the assessment of the environmental risk posed by pharmaceuticals originating from hospital effluents

(2014) Mustafa Al Aukidy et al.   SCIENCE OF THE TOTAL ENVIRONMENT

Screening for pharmaceutical transformation products formed in river sediment by combining ultrahigh performance liquid chromatography/high resolution mass spectrometry with a rapid data-processing method

(2013) Zhe Li et al.   ANALYTICA CHIMICA ACTA

Unusual biotransformation products of the sesquiterpene lactone budlein A by Aspergillus species

(2013) Nilton Syogo Arakawa et al.   PHYTOCHEMISTRY

EU-wide monitoring survey on emerging polar organic contaminants in wastewater treatment plant effluents

(2013) Robert Loos et al.   WATER RESEARCH

Screening level mixture risk assessment of pharmaceuticals in STP effluents

(2013) Thomas Backhaus et al.   WATER RESEARCH

Reactive Metabolites in the Biotransformation of Molecules Containing a Furan Ring

(2012) Lisa A. Peterson   CHEMICAL RESEARCH IN TOXICOLOGY

Biotransformation of natural compounds. Oxido-reduction of Sch-642305 by Aspergillus ochraceus ATCC 1009

(2011) Emilie Adelin et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Transformation products of pharmaceuticals in surface waters and wastewater formed during photolysis and advanced oxidation processes – Degradation, elucidation of byproducts and assessment of their biological potency

(2011) D. Fatta-Kassinos et al.   CHEMOSPHERE

Furosemide-induced genotoxicity and cytotoxicity in the hepatocytes, but weak genotoxicity in the bone marrow cells of mice

(2011) Sambhu Charan Mondal et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Preparative access to transformation products (TPs) of furosemide: a versatile application of anodic oxidation

(2011) Céline Laurencé et al.   TETRAHEDRON

Study of the toxicity of sulfamethoxazole and its degradation products in water by a bioluminescence method during application of the electro-Fenton treatment

(2010) A. Dirany et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Microbial production of phase I and phase II metabolites of propranolol

(2010) Cyrille Marvalin et al.   XENOBIOTICA

PHARMACEUTICAL METABOLITES IN THE ENVIRONMENT: ANALYTICAL CHALLENGES AND ECOLOGICAL RISKS

(2009) Mary D. Celiz et al.   ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY

Cunninghamella – A microbial model for drug metabolism studies – A review

(2008) Sepuri Asha et al.   BIOTECHNOLOGY ADVANCES

Human pharmaceuticals in surface waters

(2007) Jean-Philippe Besse et al.   TOXICOLOGY LETTERS